Safety pharmacology as per ICH and OECD guidelines.

Safety pharmacology is an important branch of nonclinical drug safety assessment that focuses on identifying the potential undesirable pharmacodynamic effects of a pharmaceutical substance on vital physiological functions. According to the ICH S7A guideline, safety pharmacology studies are designed to investigate undesirable effects that may occur at exposures within the therapeutic range and above. The primary aim is to detect potential risks to human safety before a drug is widely used in clinical practice. These studies also help in evaluating adverse pharmacodynamic or pathophysiological effects observed during other nonclinical or clinical investigations and, where necessary, in understanding their underlying mechanisms.

The core concept of safety pharmacology is to evaluate the functional effects of a drug on major organ systems that are essential for survival. The central nervous system (CNS), cardiovascular system, and respiratory system constitute the principal safety pharmacology core battery under ICH S7A. Parameters such as behaviour, motor activity, blood pressure, heart rate, cardiac electrophysiology, respiratory rate, and respiratory function may be evaluated depending on the characteristics of the test substance. Additional or supplemental studies involving systems such as the gastrointestinal, renal, endocrine, or other physiological systems may be conducted when scientifically justified by the pharmacological properties or observed adverse effects of the drug.

The OECD framework complements nonclinical safety assessment by providing internationally recognised principles for the testing and quality assurance of chemical safety data, including OECD Test Guidelines and Good Laboratory Practice (GLP) principles. While ICH S7A specifically provides the regulatory framework for safety pharmacology studies of human pharmaceuticals, OECD guidelines support standardised, reliable, and internationally acceptable approaches to nonclinical testing.

Thus, safety pharmacology plays a crucial role in modern drug development by identifying functional hazards, supporting risk assessment, guiding clinical trial design, and improving the overall safety profile of new pharmaceutical products

Click the link below to access MCQs

https://drive.google.com/file/d/1TwaLP8aFUeK9wI6L4jgjbjKx61bE80oL/view?usp=drive_link